What Exactly Are GLP-1 Drugs, and Why the Buzz
doi: 10.1111/j.1464-5491.1994.tb00277.x 221
Additional research into its uses, effectiveness, and side effects is ongoing
In advanced-stage disease, immune checkpoint inhibitor-based therapy is the preferred treatment regimen
:max_bytes(150000):strip_icc()/VWH-GettyImages-1987871747-09a35e1b5bce489f8fd887c389ee5c2f.jpg)
Back to Journals Journal of Inflammation Research Volume 17 Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors Authors Rahim K, Shan M, Ul Haq I, Nawaz MN , Maryam S , Alturki MS, Al Khzem AH , Metwally K, Cavalu S, Alqifari SF , Yahya G Received 18 October 2023 Accepted for publication 9 March 2024 Published 23 March 2024 Volume 2024:17 Pages 18971917 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Adam Bachstetter Kashif Rahim, 1 Muhammad Shan, 2 Ihtisham Ul Haq, 3 5 Muhammad Naveed Nawaz, 2 Sajida Maryam, 3, 4 Mansour S Alturki, 6 Abdulaziz H Al Khzem, 6 Kamel Metwally, 7 Simona Cavalu, 8 Saleh F Alqifari, 9 Galal Yahya 10 1 School of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, Peoples Republic of China